Business Description
Sonic Healthcare Ltd
NAICS : 621511
SIC : 8071
ISIN : AU000000SHL7
Share Class Description:
FRA:SAB: Ordinary SharesDescription
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.14 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | 2.72 | |||||
| Interest Coverage | 5.39 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.31 | |||||
| Beneish M-Score | -2.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1 | |||||
| 3-Year EBITDA Growth Rate | -13.2 | |||||
| 3-Year EPS without NRI Growth Rate | -26.8 | |||||
| 3-Year FCF Growth Rate | -33.4 | |||||
| 3-Year Book Growth Rate | 7.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 11.53 | |||||
| Future 3-5Y Total Revenue Growth Rate | 6.38 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 30.43 | |||||
| 9-Day RSI | 36.01 | |||||
| 14-Day RSI | 40.63 | |||||
| 6-1 Month Momentum % | 7.83 | |||||
| 12-1 Month Momentum % | -8.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.01 | |||||
| Quick Ratio | 0.92 | |||||
| Cash Ratio | 0.28 | |||||
| Days Inventory | 52.02 | |||||
| Days Sales Outstanding | 41.95 | |||||
| Days Payable | 119.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.95 | |||||
| Dividend Payout Ratio | 0.98 | |||||
| 3-Year Dividend Growth Rate | 6.5 | |||||
| Forward Dividend Yield % | 3.95 | |||||
| 5-Year Yield-on-Cost % | 5.16 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | -6.68 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 83.75 | |||||
| Operating Margin % | 9.14 | |||||
| Net Margin % | 5.72 | |||||
| FCF Margin % | 5.51 | |||||
| ROE % | 6.56 | |||||
| ROA % | 3.68 | |||||
| ROIC % | 4.75 | |||||
| ROC (Joel Greenblatt) % | 30.23 | |||||
| ROCE % | 7.51 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.57 | |||||
| Forward PE Ratio | 24.12 | |||||
| PE Ratio without NRI | 25.57 | |||||
| Shiller PE Ratio | 16.05 | |||||
| Price-to-Owner-Earnings | 13.12 | |||||
| PEG Ratio | 3.36 | |||||
| PS Ratio | 1.46 | |||||
| PB Ratio | 1.66 | |||||
| Price-to-Free-Cash-Flow | 26.61 | |||||
| Price-to-Operating-Cash-Flow | 12.21 | |||||
| EV-to-EBIT | 19.48 | |||||
| EV-to-Forward-EBIT | 18.52 | |||||
| EV-to-EBITDA | 10.35 | |||||
| EV-to-Forward-EBITDA | 9.87 | |||||
| EV-to-Revenue | 1.93 | |||||
| EV-to-Forward-Revenue | 1.8 | |||||
| EV-to-FCF | 34.63 | |||||
| Price-to-Projected-FCF | 0.71 | |||||
| Price-to-DCF (Earnings Based) | 1.85 | |||||
| Price-to-DCF (FCF Based) | 1.21 | |||||
| Price-to-Median-PS-Value | 0.76 | |||||
| Price-to-Peter-Lynch-Fair-Value | 3.38 | |||||
| Earnings Yield (Greenblatt) % | 5.14 | |||||
| FCF Yield % | 3.74 | |||||
| Forward Rate of Return (Yacktman) % | 15.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sonic Healthcare Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 5,497.952 | ||
| EPS (TTM) (€) | 0.659 | ||
| Beta | 0.85 | ||
| Volatility % | 23.1 | ||
| 14-Day RSI | 40.63 | ||
| 14-Day ATR (€) | 0.219201 | ||
| 20-Day SMA (€) | 16.9303 | ||
| 12-1 Month Momentum % | -8.92 | ||
| 52-Week Range (€) | 14.1 - 19.7 | ||
| Shares Outstanding (Mil) | 480.4 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sonic Healthcare Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sonic Healthcare Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sonic Healthcare Ltd Frequently Asked Questions
What is Sonic Healthcare Ltd(FRA:SAB)'s stock price today?
The current price of FRA:SAB is €16.23. The 52 week high of FRA:SAB is €19.70 and 52 week low is €14.10.
When is next earnings date of Sonic Healthcare Ltd(FRA:SAB)?
The next earnings date of Sonic Healthcare Ltd(FRA:SAB) is 2025-02-20 Est..
Does Sonic Healthcare Ltd(FRA:SAB) pay dividends? If so, how much?
The Dividend Yield %  of Sonic Healthcare Ltd(FRA:SAB) is 3.95% (As of Today), Highest Dividend Payout Ratio of Sonic Healthcare Ltd(FRA:SAB) was 0.98. The lowest was 0.31. And the median was 0.7. The  Forward Dividend Yield % of Sonic Healthcare Ltd(FRA:SAB) is 3.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers